(Post-pandemic Era)-Global Genomics Personalized Health Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2023

Report ID: 270553 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Genomics Personalized Health Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 NGS Platforms -Product Introduction and Major Manufacturers
      1.1.2 RT-PCR -Product Introduction and Major Manufacturers
      1.1.3 Microarray -Product Introduction and Major Manufacturers
      1.1.4 Sequencing and Genetic Analyzers -Product Introduction and Major Manufacturers
      1.1.5 Other -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2020-2027)
    2.2 Regional Market Share in Terms of Revenue (2020-2027)
    2.3 Regional Market Share in Terms of Consumption (2020-2027)
3 Global Genomics Personalized Health Market Assessment by Type
    3.1 Global Genomics Personalized Health Production by Type (2016-2027)
    3.2 Global Genomics Personalized Health Revenue by Type (2016-2027)
    3.3 North America Genomics Personalized Health Production and Revenue by Type (2016-2027)
    3.4 Asia Genomics Personalized Health Production and Revenue by Type (2016-2027)
    3.5 Europe Genomics Personalized Health Production and Revenue by Type (2016-2027)
    3.6 Middle East & Africa Genomics Personalized Health Production and Revenue by Type (2016-2027)
    3.7 South America Genomics Personalized Health Production and Revenue by Type (2016-2027)

4 Global Genomics Personalized Health Market Assessment by Application
    4.1 Historical & Forecast Global Genomics Personalized Health Consumption, Different Application Field (2016-2027)
    4.2 Historical & Forecast North America Genomics Personalized Health Consumption, Different Application Field (2016-2027)
    4.3 Historical & Forecast Asia Genomics Personalized Health Consumption, Different Application Field (2016-2027)
    4.4 Historical & Forecast Europe Genomics Personalized Health Consumption, Different Application Field (2016-2027)
    4.5 Historical & Forecast Middle East & Africa Genomics Personalized Health Consumption, Different Application Field (2016-2027)
    4.6 Historical & Forecast South America Genomics Personalized Health Consumption, Different Application Field (2016-2027)

5 North America
    5.1 US Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.2 Canada Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.3 Mexico Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6 Asia
    6.1 China Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.2 Japan Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.3 India Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.4 Korea Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.5 Southeat Asia Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7 Europe
    7.1 Germany Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.2 UK Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.3 France Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.4 Russia Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.5 Italy Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8 Middle East and Africa
    8.1 Saudi Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.2 UAE Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.3 Egypt Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.4 Nigeria Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.5 South Africa Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9 South America
    9.1 Brazil Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.2 Argentina Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.3 Colombia Genomics Personalized Health Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
10 Global Genomics Personalized Health Average Price Trend
    10.1 Market Price for Each Type of Genomics Personalized Health in North America (2016-2027)
    10.2 Market Price for Each Type of Genomics Personalized Health in Asia (2016-2027)
    10.3 Market Price for Each Type of Genomics Personalized Health in Europe (2016-2027)
    10.4 Market Price for Each Type of Genomics Personalized Health in Middle East & Africa (2016-2027)
    10.5 Market Price for Each Type of Genomics Personalized Health in South America (2016-2027)

11 Value Chain (Impact of COVID-19)
    11.1 Genomics Personalized Health Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Genomics Personalized Health Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Genomics Personalized Health Competitive Analysis
     12.1 QIAGEN
        12.1.1 QIAGEN Company Profiles
        12.1.2 QIAGEN Product Introduction
        12.1.3 QIAGEN Genomics Personalized Health Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 Illumina
        12.2.1 Illumina Company Profiles
        12.2.2 Illumina Product Introduction
        12.2.3 Illumina Genomics Personalized Health Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 Thermo Fisher Scientific
        12.3.1 Thermo Fisher Scientific Company Profiles
        12.3.2 Thermo Fisher Scientific Product Introduction
        12.3.3 Thermo Fisher Scientific Genomics Personalized Health Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 Bio-Rad Laboratories
        12.4.1 Bio-Rad Laboratories Company Profiles
        12.4.2 Bio-Rad Laboratories Product Introduction
        12.4.3 Bio-Rad Laboratories Genomics Personalized Health Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
     12.5 Interleukin Genetics
        12.5.1 F. Hoffmann-La Roche Company Profiles
        12.5.2 F. Hoffmann-La Roche Product Introduction
        12.5.3 F. Hoffmann-La Roche Genomics Personalized Health Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
     12.6 Lonza Group
        12.6.1 Lonza Group Company Profiles
        12.6.2 Lonza Group Product Introduction
        12.6.3 Lonza Group Genomics Personalized Health Production, Revenue (2015-2020)
        12.6.4 SWOT Analysis
     12.7 Invitae Corporation
        12.7.1 Invitae Corporation Company Profiles
        12.7.2 Invitae Corporation Product Introduction
        12.7.3 Invitae Corporation Genomics Personalized Health Production, Revenue (2015-2020)
        12.7.4 SWOT Analysis
     12.8 Genetic Technologies
        12.8.1 Genetic Technologies Company Profiles
        12.8.2 Genetic Technologies Product Introduction
        12.8.3 Genetic Technologies Genomics Personalized Health Production, Revenue (2015-2020)
        12.8.4 SWOT Analysis
     12.9 Interleukin Genetics
        12.9.1 Interleukin Genetics Company Profiles
        12.9.2 Interleukin Genetics Product Introduction
        12.9.3 Interleukin Genetics Genomics Personalized Health Production, Revenue (2015-2020)
        12.9.4 SWOT Analysis
     12.10 Eastern Biotech and Life Sciences
        12.10.1 Eastern Biotech and Life Sciences Company Profiles
        12.10.2 Eastern Biotech and Life Sciences Product Introduction
        12.10.3 Eastern Biotech and Life Sciences Genomics Personalized Health Production, Revenue (2015-2020)
        12.10.4 SWOT Analysis
     12.11 DNA Genotek
     12.12 uBiome
     12.13 XCode Life Sciences
13 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2020)
    Figure Global Genomics Personalized Health Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2016-2027)
    Table Regional Market Share in Terms of Production (2020-2027)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2020-2027)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Genomics Personalized Health Production (K Unit) by Type (2016-2027)
    Figure Global Genomics Personalized Health Production (K Unit) and Growth Rate (2016-2027)
    Figure Global Genomics Personalized Health Production Market Share (%) by Type (2019 -2020)
    Table Global Genomics Personalized Health Revenue (Million USD) by Type (2016-2027)
    Figure Global Genomics Personalized Health Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Global Genomics Personalized Health Revenue Market Share (%) by Type (2019-2020)
    Figure North America Genomics Personalized Health Production (K Unit) by Type (2016-2027)
    Figure North America Genomics Personalized Health Production (K Unit) and Growth Rate (2016-2027)
    Figure North America Genomics Personalized Health Revenue (Million USD) by Type (2016-2027)
    Figure North America Genomics Personalized Health Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Asia Genomics Personalized Health Production (K Unit) by Type (2016-2027)
    Figure Asia Genomics Personalized Health Production (K Unit) and Growth Rate (2016-2027)
    Figure Asia Genomics Personalized Health Revenue (Million USD) by Type (2016-2027)
    Figure Asia Genomics Personalized Health Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Europe Genomics Personalized Health Production (K Unit) by Type (2016-2027)
    Figure Europe Genomics Personalized Health Production (K Unit) and Growth Rate (2016-2027)
    Figure Europe Genomics Personalized Health Revenue (Million USD) by Type (2016-2027)
    Figure Europe Genomics Personalized Health Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Middle East & Africa Genomics Personalized Health Production (K Unit) by Type (2016-2027)
    Figure Middle East & Africa Genomics Personalized Health Production (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Genomics Personalized Health Revenue (Million USD) by Type (2016-2027)
    Figure Middle East & Africa Genomics Personalized Health Revenue (Million USD) and Growth Rate (2016-2027)
    Figure South America Genomics Personalized Health Production (K Unit) by Type (2016-2027)
    Figure South America Genomics Personalized Health Production (K Unit) and Growth Rate (2016-2027)
    Figure South America Genomics Personalized Health Revenue (Million USD) by Type (2016-2027)
    Figure South America Genomics Personalized Health Revenue (Million USD) and Growth Rate (2016-2027)
    Table Historical & Forecast Genomics Personalized Health Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Genomics Personalized Health Different Application Field Consumption (K Unit)
    Figure North America Genomics Personalized Health Consumption (K Unit) and Growth Rate (2016-2027)
    Figure North America Genomics Personalized Health Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Genomics Personalized Health Different Application Field Consumption (K Unit)
    Figure Asia Genomics Personalized Health Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Asia Genomics Personalized Health Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Genomics Personalized Health Different Application Field Consumption (K Unit)
    Figure Europe Genomics Personalized Health Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Europe Genomics Personalized Health Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Genomics Personalized Health Different Application Field Consumption (K Unit)
    Figure Middle East & Africa Genomics Personalized Health Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Genomics Personalized Health Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Genomics Personalized Health Different Application Field Consumption (K Unit)
    Figure South America Genomics Personalized Health Consumption (K Unit) and Growth Rate (2016-2027)
    Figure South America Genomics Personalized Health Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Genomics Personalized Health Different Application Field Consumption (K Unit)
    Table US Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Canada Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Mexico Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table China Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Japan Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table India Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Korea Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Southeast Asia Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Germany Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UK Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table France Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Russia Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Italy Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Saudi Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UAE Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Egypt Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Nigeria Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table South Africa Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Brazil Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Argentina Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Colombia Genomics Personalized Health Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Market Price (USD/Unit) for Each Type of Genomics Personalized Health in China
    Table Market Price (USD/Unit) for Each Type of Genomics Personalized Health in EU
    Table Market Price (USD/Unit) for Each Type of Genomics Personalized Health in USA
    Table Market Price (USD/Unit) for Each Type of Genomics Personalized Health in Japan
    Table Market Price (USD/Unit) for Each Type of Genomics Personalized Health in India
    Table Market Price (USD/Unit) for Each Type of Genomics Personalized Health in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Genomics Personalized Health in South America
    Figure Value Chain Structure of Genomics Personalized Health
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Genomics Personalized Health
    Figure Cost Structure of Genomics Personalized Health in 2020
    Table Distributors/Traders List
    Table QIAGEN Profiles
    Table QIAGEN Genomics Personalized Health Product Introduction
    Figure QIAGEN Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure QIAGEN SWOT Analysis
    Table Illumina Profiles
    Table Illumina Genomics Personalized Health Product Introduction
    Figure Illumina Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Illumina SWOT Analysis
    Table Thermo Fisher Scientific Profiles
    Table Thermo Fisher Scientific Genomics Personalized Health Product Introduction
    Figure Thermo Fisher Scientific Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Thermo Fisher Scientific SWOT Analysis
    Table Bio-Rad Laboratories Profiles
    Table Bio-Rad Laboratories Genomics Personalized Health Product Introduction
    Figure Bio-Rad Laboratories Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Bio-Rad Laboratories SWOT Analysis
    Table F. Hoffmann-La Roche Profiles
    Table F. Hoffmann-La Roche Genomics Personalized Health Product Introduction
    Figure F. Hoffmann-La Roche Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure F. Hoffmann-La Roche SWOT Analysis
    Table Lonza Group Profiles
    Table Lonza Group Genomics Personalized Health Product Introduction
    Figure Lonza Group Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Lonza Group SWOT Analysis
    Table Invitae Corporation Profiles
    Table Invitae Corporation Genomics Personalized Health Product Introduction
    Figure Invitae Corporation Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Invitae Corporation SWOT Analysis
    Table Genetic Technologies Profiles
    Table Genetic Technologies Genomics Personalized Health Product Introduction
    Figure Genetic Technologies Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Genetic Technologies SWOT Analysis
    Table Interleukin Genetics Profiles
    Table Interleukin Genetics Genomics Personalized Health Product Introduction
    Figure Interleukin Genetics Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Interleukin Genetics SWOT Analysis
    Table Eastern Biotech and Life Sciences Profiles
    Table Eastern Biotech and Life Sciences Genomics Personalized Health Product Introduction
    Figure Eastern Biotech and Life Sciences Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Eastern Biotech and Life Sciences SWOT Analysis
    Table DNA Genotek Profiles
    Table DNA Genotek Genomics Personalized Health Product Introduction
    Figure DNA Genotek Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure DNA Genotek SWOT Analysis
    Table uBiome Profiles
    Table uBiome Genomics Personalized Health Product Introduction
    Figure uBiome Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure uBiome SWOT Analysis
    Table XCode Life Sciences Profiles
    Table XCode Life Sciences Genomics Personalized Health Product Introduction
    Figure XCode Life Sciences Genomics Personalized Health Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global Genomics Personalized Health Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global Genomics Personalized Health Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global Genomics Personalized Health Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports